第一单位：
Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.
作者：
Paula,Rodriguez-Marquez [1]
;
Maria E,Calleja-Cervantes [2]
;
Guillermo,Serrano [3]
;
Aina,Oliver-Caldes [4]
;
Maria L,Palacios-Berraquero [5]
;
Angel,Martin-Mallo [1]
;
Cristina,Calviño [5]
;
Marta,Español-Rego [6]
;
Candela,Ceballos [7]
;
Teresa,Lozano [8]
;
Patxi,San Martin-Uriz [1]
;
Amaia,Vilas-Zornoza [9]
;
Saray,Rodriguez-Diaz [1]
;
Rebeca,Martinez-Turrillas [9]
;
Patricia,Jauregui [5]
;
Diego,Alignani [10]
;
Maria C,Viguria [7]
;
Margarita,Redondo [7]
;
Mariona,Pascal [6]
;
Beatriz,Martin-Antonio [4]
;
Manel,Juan [11]
;
Alvaro,Urbano-Ispizua [4]
;
Paula,Rodriguez-Otero [5]
;
Ana,Alfonso-Pierola [12]
;
Bruno,Paiva [13]
;
Juan J,Lasarte [8]
;
Susana,Inoges [14]
;
Ascension,Lopez-Diaz de Cerio [14]
;
Jesus,San-Miguel [15]
;
Carlos,Fernandez de Larrea [4]
;
Mikel,Hernaez [16]
;
Juan R,Rodriguez-Madoz [9]
;
Felipe,Prosper [15]
作者单位：
Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.
[1]
Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.;Computational Biology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.
[2]
Computational Biology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.
[3]
Department of Hematology, Hospital Clinic de Barcelona, IDIBAPS, Universidad de Barcelona, Barcelona, Spain.
[4]
Hematology and Cell Therapy Department, Clínica Universidad de Navarra (CUN), Pamplona, Spain.
[5]
Department of Immunology, Hospital Clinic de Barcelona, IDIBAPS, Universidad de Barcelona, Barcelona, Spain.
[6]
Hematology Service, Hospital Universitario de Navarra, IdiSNA, Pamplona, Spain.
[7]
Immunology and Immunotherapy Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.
[8]
Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
[9]
Flow Cytometry Core, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.
[10]
Department of Immunology, Hospital Clinic de Barcelona, IDIBAPS, Universidad de Barcelona, Barcelona, Spain.;Immunotherapy platform Hospital Sant Joan de Déu, Barcelona, Spain.
[11]
Hematology and Cell Therapy Department, Clínica Universidad de Navarra (CUN), Pamplona, Spain.;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
[12]
Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.;Flow Cytometry Core, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.
[13]
Hematology and Cell Therapy Department, Clínica Universidad de Navarra (CUN), Pamplona, Spain.;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.;Immunology and Immunotherapy Department, Clínica Universidad de Navarra (CUN), Pamplona, Spain.
[14]
Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.;Hematology and Cell Therapy Department, Clínica Universidad de Navarra (CUN), Pamplona, Spain.;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.;Cancer Center Universidad de Navarra (CCUN), Pamplona, Spain.
[15]
Computational Biology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.;Data Science and Artificial Intelligence Institute (DATAI), Universidad de Navarra, Pamplona, Spain.
[16]
DOI
10.1126/sciadv.abo0514
PMID
36179026
发布时间
2023-03-30
换一批
